Vulvovaginal candidiasis (VVC) is one of the most common types of vaginal infections in
women around the world and is often underestimated by both patients and doctors …

Candida auris has unprecedently emerged as a multidrug resistant fungal pathogen,
considered a serious global threat due to its potential to cause nosocomial outbreaks and …

Candida auris recently emerged as an urgent public health threat, causing outbreaks of
invasive infections in healthcare settings throughout the world. This fungal pathogen persists …

Candida auris is an emerging fungal pathogen with unusual evolutionary history—there are
multiple distinct phylogeographic clades showing a near simultaneous transition from a …

Candida auris has been described as an emerging yeast species during the last decade. As
many as 25% of its strains may naturally exhibit multi-drug resistance to the currently …

Candida auris is an emerging healthcare-associated fungal pathogen that has become a
serious global health threat. Current treatment options are limited due to drug resistance …

Candida auris is a fungal pathogen of humans responsible for nosocomial infections with
high mortality rates. High levels of resistance to antifungal drugs and environmental …

A key component of the insect immune response is melanin production, including within
nodules, or aggregations of immune cells surrounding microbes. Melanization produces …

Galleria mellonella is a model that uses adult larvae to assess the prophylactic, therapeutic,
and acute toxic potential of substances. Given their benefits, G. mellonella models are being …

Amphotericin B (AmB) is the gold standard for antifungal drugs. However, AmB systemic
administration is restricted because of its side effects. Here, we report AmB loaded in natural …